Skip to main content
Log in

Cytohistochemical studies on estrogen receptors of breast cancer tissue using an immunoperoxidase technique

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

The estrogen receptors (ER) in breast cancer tissues were investigated in 122 patients using an immunoperoxidase method. ER (+) were evident in 77 of 122 patients (63.1 per cent). If classified according to pre-and postmenopausal subjects. ER (+) was seen in 61.4 per cent and ER (−) in 32.9 per cent before menopause, and ER (+) in 65.4 per cent and ER (−) in 30.8 per cent after menopause with no marked difference between the two. If classified according to histological type, ER (+) was seen in 73.2 per cent of those with papillotubular carcinoma and in 62.0 per cent of those with scirrhous carcinoma, whereas ER (−) was seen in 44.9 per cent of those with medullary tubular carcinoma. ER (+) was seen in carcinoma with apocrine metaplasia, lobular carcinoma and Paget's carcinoma. Concerning the relationship between primary tumors and metastatic lymph nodes, ER (+) for both was seen in 20 of 41 patients (48.8 per cent) whereas ER (−) for both was found in 9 of 41 patients (22.0 per cent). Four patients with local recurrences had a positive ER (+) at the beginning of treatment, but the ER became negative after hormonal treatment and chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yasutomi M. An improved freeze-substitution method for histochemical studies. Acta Med Osaka Univ 1964; 16: 181–190. (in Japanese)

    Google Scholar 

  2. Dandliker WB, Levision SA, Brawn RJ. Hormone binding by cells and cell fragments as visualized by fluorescence microscopy. Res Commun Chem Pathol Pharmacol 1976; 14: 103–109.

    PubMed  CAS  Google Scholar 

  3. Levision SA, Dandliker WB, Brawn RJ, Vanderlaan WP. Fluorescence polarization measurement of the hormone binding site interaction. Endocrinology 1976; 99: 1129–1143.

    Article  Google Scholar 

  4. Neci I, Beccati MD, Piffanelli A, Lanza G. Detection and dynamic localization of estradiol receptor complexes in intact target cells by immunofluorescence technique. J Steroid Biochem 1976; 7: 505–510.

    Article  Google Scholar 

  5. Pertschuk LP. Detection of estrogen binding in human mammary carcinoma by immunofluorescence; A new technique ultilizing the binding hormone in a polymerized state. Res Commun Chem Pathol Pharmacol 1976; 14: 771–774.

    PubMed  CAS  Google Scholar 

  6. Kurzon RM, Sternbergen LA. Estrogen receptor immunocytochemistry. J Histochem Cytochem 1978; 26: 803–808.

    PubMed  CAS  Google Scholar 

  7. Shimizu M, Wajima O, Miura M, Katayama I. PAP immunoperoxidase method demonstrating endogenous estrogen in breast carcinomas. Cancer 1983; 52: 486–492.

    Article  PubMed  CAS  Google Scholar 

  8. McGuire WL. Current status of estrogen receptors in human breast cancer. Cancer 1975; 36: 638–644.

    Article  PubMed  CAS  Google Scholar 

  9. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WC. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 1977; 37: 106–110.

    PubMed  CAS  Google Scholar 

  10. Parl FF, Wagner RK. The histopathological evaluation of human breast cancer 1980; 46: 362–367.

    Article  PubMed  CAS  Google Scholar 

  11. Silfversward C, Gustafsson J, Gustafsson SA, Humla S, Nordenskjold B, Wallgren A, Wrange O. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 1980; 45: 2001–2005.

    Article  PubMed  CAS  Google Scholar 

  12. Tilley WD, Keightley DD, Cant ELM. Intersite variation of estrogen receptors in human breast cancers. Br J Cancer 1978; 38: 544–546.

    PubMed  CAS  Google Scholar 

  13. Lee SH. Cancer cell estrogen receptor of human mammary carcinoma. Cancer 1979; 44: 1–12.

    Article  PubMed  CAS  Google Scholar 

  14. Mercer WD, Lippman ME, Wahl TM, Carlson CA, Wahl DA, Lezotte D, Teague PO. The use of immunocytochemical techniques for the detection of steroid hormones in breast cancer cells. Cancer 1980; 46: 2859–2868.

    Article  PubMed  CAS  Google Scholar 

  15. Taylor CR, Cooper CL, Kurman RJ, Goevelsmann U, Markland FS Jr. Detection of estrogen receptor in breast and endometrial carcinoma by the immunoperoxidase technique. Cancer 1981; 47: 2634–2640.

    Article  PubMed  CAS  Google Scholar 

  16. Pertschuk LP, Tobin EH, Gaetjens E, Carter AC, Degenshein GA, Bloom ND, Brigati DJ. Histochemical assay of estrogen and progesterone receptors in breast cancer; Correlation with biochemical assay and patients' response to endocrine therapies. Cancer 1980; 46: 2896–2901.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

These data were presented at the 3rd EORTC, Amsterdam, April 27–29, 1983.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwasa, Z., Matsumoto, K., Yamato, M. et al. Cytohistochemical studies on estrogen receptors of breast cancer tissue using an immunoperoxidase technique. The Japanese Journal of Surgery 15, 195–199 (1985). https://doi.org/10.1007/BF02469886

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02469886

Key Words

Navigation